Author: healthprofessionalradio

Dr. Dirk Huebner, MD, Chief Medical Officer at Aptevo Therapeutics, a biotech company, discusses the company’s focus on bringing novel immuno-oncology therapeutics to market. They leverage the innovative ADAPTIR™ and ADAPTIR-FLEX™ platform technologies to create therapeutic candidates designed to improve outcomes for cancer patients.

Psychiatrist, Dr. Rakesh Amin, MD, discusses the toll that schizophrenia takes on caregivers, how caregivers of schizophrenia patients can best support themselves, as well as their patients, and how caregivers can help patients establish a successful treatment plan. Dr. Amin talks about newer treatment options, such as long-acting injectables, that can help improve patient adherence, reduce stress, and allow freedom from taking a pill every day.

Hema Tallman, SVP and Global Head of BioLife Plasma Services at Takeda, an industry leader in the collection of high-quality plasma and a supporting driver in the production of life-saving plasma-derived therapies (PDTs). She discusses the importance of the consumer experience by leveraging her experience in health retail as she drives BioLife’s efforts to create a future-ready organization that can meet the growing needs of patients who rely on PDTs. Tallman also shares her personal insights that supported her growth as a leader.

Dr. David Bearss, PhD, President and CEO at Halia Therapeutics, a clinical-stage biopharma company developing novel therapies to improve the lives of patients with inflammatory disorders and neurological diseases discusses the company’s lead compound, HT-6184, which prevents the formation of the NLRP3 inflammasome complex and subsequently inhibits the production and release of pro-inflammatory cytokines to ultimately shut down chronic inflammation. Halia is currently conducting a Phase 1 trial to evaluate the safety, tolerability, and pharmacokinetics of HT-6184 in healthy human participants.

Schizophrenia is a serious and complex mental illness that left untreated can disrupt a person’s relationships, physical health, and plans for the future – and it may even lead to repeated cycles of crisis with recurrent episodes. There is hope for people who have schizophrenia to lead a normal life with the right support and treatment. Here to discuss schizophrenia and the importance of managing it is Jonathan Llamas, a certified psychiatric mental health nurse practitioner and Doctor of Nursing Practice.  

Mark McDonough, CEO of ChromaCode, a molecular diagnostics company, discusses how ChromaCode  technology provides a cost-effective, rapid, and accurate method of testing  clinically actionable biomarkers. He also talks about the partnership with MedGenome to bring affordable diagnostics to India and the middle east.

Amelia Korangy, Director of External Affairs Strategy and Programs at ViiV Healthcare – the only pharmaceutical company solely focused on HIV, discusses ViiV’s investment in HIV prevention for Black women. ViiV’s Risk to Reasons initiative, which includes community grants and resources, recently launched free online activity books to help change the HIV prevention narrative for Black women. The series of three activity books, developed in partnership with Black women advocates across the country will help women with reasons for prevention guide conversations with themselves, their partners and their healthcare professionals. ViiV’s community liaisons are partnering with Risk to Reasons grantees and other community organizations across the country to use these activity books and normalize conversations about HIV prevention and sexual health.

Dr. Steve Marcus, CEO of Cantex Pharmaceuticals, a clinical-stage pharmaceutical company focused on developing transformative therapies for cancer and other life-threatening medical conditions for which new treatments are urgently needed discusses 2 clinical trials for azeliragon, an orally active, small molecule, antagonist of the receptor for advanced glycation end products (RAGEs) in various cancers.

Greg Pierce, SVP and GM of Specialty, Health & Wellness at Synchrony, a financial services company, discusses the over-the-counter (OTC) hearing aids ruling, ways to find and pay an audiologist who can ensure the patient has the right hearing aid for their needs, and how consumers can utilize Synchrony’s network of 260,000 providers (and their 90-year expertise in financing) to ease the path they’ll take in receiving the hearing care they need.

The U.S. federal government designated May 11, 2023, as the official end of the COVID-19 health emergency​ in the U.S. But the virus is still active and the leading cause of death in the U.S. among the elderly and immunocompromised, so, it’s important to take precautions like getting vaccinated and masking…especially if you have a compromised immune system. Here to talk about the realities of navigating post-pandemic life is returning guest Dr. Dorry Segev, Director at NYU Center for Surgical and Transplant Research along with advocate and caregiver Tracy Shaw, Board Chair, Immune Deficiency Foundation (IDF).